Three or more routes for leukocyte migration into the central nervous system

被引:773
作者
Ransohoff, RM
Kivisäkk, P
Kidd, G
机构
[1] Cleveland Clin Fdn, Mellen Ctr Multiple Sclerosis Treatment & Res, Dept Neurol, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nri1130
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Leukocyte migration into and through tissues is fundamental to normal physiology, immunopathology and host defence. Leukocyte entry into the central nervous system (CNS) is restricted, in part, because of the blood brain barrier (BBB). During the past decade, crucial components that are involved in the process of leukocyte migration have been identified and progress has been made in understanding the mechanisms of neuroinflammatory reactions. In this review, present knowledge of the trafficking determinants that guide the migration of leukocytes is superimposed onto the vascular and compartmental anatomy of the CNS. We discuss three distinct routes for leukocytes to enter the CNS and consider how different populations of leukocytes use trafficking signals to gain entry.
引用
收藏
页码:569 / 581
页数:13
相关论文
共 128 条
[41]   PERIVASCULAR MICROGLIAL CELLS OF THE CNS ARE BONE-MARROW DERIVED AND PRESENT ANTIGEN INVIVO [J].
HICKEY, WF ;
KIMURA, H .
SCIENCE, 1988, 239 (4837) :290-292
[42]   Migration of Hematogenous Cells Through the Blood-Brain Barrier and the Initiation of CNS Inflammation [J].
Hickey, William F. .
BRAIN PATHOLOGY, 1991, 1 (02) :97-105
[43]   ANALYSIS OF CD27 SURFACE EXPRESSION ON T-CELL SUBSETS IN MS PATIENTS AND CONTROL INDIVIDUALS [J].
HINTZEN, RQ ;
FISZER, U ;
FREDRIKSON, S ;
REP, M ;
POLMAN, CH ;
VANLIER, RAW ;
LINK, H .
JOURNAL OF NEUROIMMUNOLOGY, 1995, 56 (01) :99-105
[44]   Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis [J].
Huang, DR ;
Wang, JT ;
Kivisakk, P ;
Rollins, BJ ;
Ransohoff, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (06) :713-725
[45]   Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier [J].
Huber, JD ;
Egleton, RD ;
Davis, TP .
TRENDS IN NEUROSCIENCES, 2001, 24 (12) :719-725
[46]   Integrin affinity modulation [J].
Hughes, PE ;
Pfaff, M .
TRENDS IN CELL BIOLOGY, 1998, 8 (09) :359-364
[47]   SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN LEWIS RATS AFTER ELIMINATION OF MACROPHAGES [J].
HUITINGA, I ;
VANROOIJEN, N ;
DEGROOT, CJA ;
UITDEHAAG, BMJ ;
DIJKSTRA, CD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (04) :1025-1033
[48]   The chemokine KC, but not monocyte chemoattractant protein-1, triggers monocyte arrest on early atherosclerotic endothelium [J].
Huo, YQ ;
Weber, C ;
Forlow, SB ;
Sperandio, M ;
Thatte, J ;
Mack, M ;
Jung, S ;
Littman, DR ;
Ley, K .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (09) :1307-1314
[49]   A pathogenic role for myelin-specific CD8+ T cells in a model for multiple sclerosis [J].
Huseby, ES ;
Liggitt, D ;
Brabb, T ;
Schnabel, B ;
Öhlén, C ;
Goverman, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (05) :669-676
[50]   Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2 [J].
Izikson, L ;
Klein, RS ;
Charo, IF ;
Weiner, HL ;
Luster, AD .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (07) :1075-1080